CLINICAL_TRIALS
trial_result
· 2014-07-04
Clinical Trial Update: Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI [Phase 2]
Summary
Phase 2 clinical trial evaluating endothelin's role in microvascular dysfunction after PCI for NSTEMI has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mayo Clinic | Conditions: Myocardial Reperfusion Injury | Phase 2 | Status: COMPLETED | Results posted: 2014-07-04